Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
Clinical trial NCT03090815 · UNKNOWN
Trial details
- NCT number
- NCT03090815
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.